Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Reversible Induction Strategy Supported by HFNC Combined With Specific Anesthetic

NCT04434963 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04434963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04434963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Reversible Induction Strategy Supported by HFNC Combined With Specific Anesthetic
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2021
Completion date
December 1, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, gastric cancer, patients with uncertain difficult airway, prostatic cancer